Age-Related Molecular Degeneration Market Analysis and Forecast 2023 to 2033

Ganesh Shinde

Age-Related Molecular Degeneration Market Analysis and Forecast 2023 to 2033

The global market for age-related molecular degeneration is currently valued at US$ 11.28 million in 2023 and is expected to grow at a CAGR of 7%. Because to technology advancements in healthcare, the market is expected to reach US$ 22.19 million by 2033.

The increasing prevalence of AMD and a strong product pipeline are anticipated to be the major drivers for the growth of age-related molecular degeneration market. According to the WHO, around 196 million people were affected by age-related macular degeneration globally in 2020, including over 10.4 million moderate-to-severe vision impairment cases.

Globally, advanced age-related macular degeneration is the primary factor in irreversible blindness and visual impairment. As a result, the market for age-related macular degeneration is anticipated to experience significant growth over the forecast period.

Most severe eye conditions are rising globally, and vision loss is becoming a significant public health issue and increase in the prevalence of the retinal disorder in many developed and developing nations drive market growth. The wet age-related macular degeneration segment is the highest contributor to the market and is expected to grow at a CAGR of 6.9% over the forecast period.

North America dominates the age-related molecular denegation market due to the presence of key market players' presence, along with recent product launches and established healthcare infrastructure, which will accelerate the market's growth in the region.

The significant R&D investments in Europe abode well for market growth. Growing awareness of macular degeneration in Asia-Pacific and the presence of key market players, and the rising elderly population in Japan all point to significant growth in the Japanese market for age-related molecular degeneration.

Competitive Landscape

F. Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Pfizer Inc., Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Amgen Inc., Biogen, Samsung Bioepis, Ophthotech Corporation are some of the key players in the age related molecular degeneration industry.

The manufacturers are involved in the production of age related molecular degeneration in a larger capacity. Research and innovation are also conducted to launch innovative product for age related molecular degeneration.

Get More Details@ https://www.futuremarketinsights.com/reports/age-related-macular-degeneration-market

Key Segments Covered in the Age-Related Molecular Degeneration Market Industry Survey

Age-Related Molecular Degeneration Market by Product Type:

Eylea
Lucentis
Beovu
Others

Age-Related Molecular Degeneration Market by Disease Type:

Dry AMD
Wet AMD

Age-Related Molecular Degeneration Market by Distribution Channel:

Hospital Pharmacy
Specialty Pharmacy
Online Pharmacy

Ganesh Shinde

2023-01-20

The global age-related molecular degeneration market is currently valued at US$ 11. The increasing prevalence of AMD and a strong product pipeline are anticipated to be the major drivers for the growth of age-related molecular degeneration market. According to the WHO, around 196 million people were affected by age-related macular degeneration globally in 2020, including over 10. Globally, advanced age-related macular degeneration is the primary factor in irreversible blindness and visual impairment. As a result, the market for age-related macular degeneration is anticipated to experience significant growth over the forecast period.

Exploring the Growth Potential of the Age-Related Macular Degeneration Market

2023-01-19

The size of the age-related macular degeneration market was $10,234 million in 2021, and it will reach $18,500 million by 2030, at a growth rate of 6. This will be due to the projected introduction of numerous therapeutic candidates from 2023 onward and the increasing burden of this ailment, which accounts for over 85% of the AMD cases. Both the dry and wet forms of macular degeneration can be fatal and need medical attention. These medications require regular and painful intraocular injections, which leads to inconvenience and discourages people from going for the treatment. Hence, pharma companies are investing to develop long-acting anti-VEGFs and vitreous implants, to make treatment less daunting.

Mushrooming Population of Geriatric People Driving Age-Related Macular Degeneration Market Growth

2022-07-14

Besides these factors, the mushrooming population of aging people is also propelling the growth of the AMD market. Since geriatric people are highly vulnerable to visual impairment, their growing population is positively impacting the worldwide demand for AMD drugs. Depending on type, the AMD market is bifurcated into dry AMD and wet AMD. This will be because of the surging population of aging people and growing incidence of the ailment. is contributing significantly to the revenue of the North American AMD market, and it is predicted to hold more than 95% of the shares by 2022.

2024-04-02

Global age related macular degeneration market is projected to witness a CAGR of 9. The different types of age related macular degeneration include dry AMD and wet AMD. Such continuous investments and initiatives towards development of therapies for age related macular degeneration are further supporting the expansion of North America age related macular degeneration market. Understanding Age-Related Macular Degeneration: Age-related macular degeneration is a degenerative eye disease that affects the macula, the central part of the retina responsible for sharp, detailed vision. Future Outlook: The future of the global age-related macular degeneration market holds promise for continued innovation and progress in AMD treatment and management.

2022-04-27

com/sample_request/10657 List of Key Companies Covered in this report:Santen Pharmaceuticals Inc. Based on age group, the dry AMD market has been divided into above 75 years, above 60 years, and above 40 years. Obesity-related macular degeneration is also on the rise in North America, along with high blood pressure from an erratic lifestyle. The African continent, particularly the Sahara subcontinent, has experienced a significant increase in dry age-related macular degeneration due to lack of vitamin A and poor dietary standards. Direct Anterior Approach Market Research Report –Global Forecast to 2027Magnetic Resonance Imaging (MRI) Market Research Report – Forecast to 2027 Endometrial Cancer Market Research Report – Forecast to 2027 Digital Wound Measurement Devices Market Research Report – Forecast to 2027 Flow Cytometry Market Research Report – Forecast to 2027 About US:Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

2020-05-08

The latest trending report Global Age Related Macular Degeneration Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.

The report will assist reader with better understanding and decision making.The Age Related Macular Degeneration Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.This report also researches and evaluates the impact of Covid-19 outbreak on the Age Related Macular Degeneration Drug industry, involving potential opportunity and challenges, drivers and risks.

We present the impact assessment of Covid-19 effects on Age Related Macular Degeneration Drug and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.

).Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/49048-age-related-macular-degeneration-drug-industry-analysis-reportThe major players covered in Age Related Macular Degeneration Drug are:Regeneron PharmaceuticalsRocheBayer HealthCareNovartisKanghong PharmaBy Type, Age Related Macular Degeneration Drug market has been segmented intoLucentisEyleaAvastinOtherBy Application, Age Related Macular Degeneration Drug has been segmented into:HospitalsClinicsOtherThe report offers in-depth assessment of the growth and other aspects of the Age Related Macular Degeneration Drug market in important countries (regions), including:North America (United States, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India and Southeast Asia)South America (Brazil, Argentina, etc.

)Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)Download Free Sample Report of Global Age Related Macular Degeneration Drug Market @ https://www.decisiondatabases.com/contact/download-sample-49048The content of the study subjects, includes a total of 15 chapters:Chapter 1, to describe Age Related Macular Degeneration Drug product scope, market overview, market opportunities, market driving force and market risks.Chapter 2, to profile the top manufacturers of Age Related Macular Degeneration Drug, with price, sales, revenue and global market share of Age Related Macular Degeneration Drug in 2018 and 2019.Chapter 3, the Age Related Macular Degeneration Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.Chapter 4, the Age Related Macular Degeneration Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.Chapter 12, Age Related Macular Degeneration Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.Chapter 13, 14 and 15, to describe Age Related Macular Degeneration Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.Purchase the complete Global Age Related Macular Degeneration Drug Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-49048All Drugs Related Reports by DecisionDatabases.com @ https://goo.gl/knWRNbAbout-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.

DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.

WHO TO FOLLOW